Technologies
A novel platform technology to produce cancer cell-targeting immunotherapeutic proteins with multispecificity.
MISSION
CytoCan is devoted to develop life-changing multispecific proteins to help patients fight cancer. We envision a near future where cancer is a controllable disease. Patient can live with cancer with no fear.
PLATFORM
A novel modular platform technology to produce cancer cell-targeting proteins with multispecific functions. By targeting immune cytokines precisely to cancer cells, our fusion proteins help reduce the risk of unintended systemic side effects.
INNOVATION
AbZed: A revolutionary humanized IgG binding domain serving as the critical connector for functional modules.
PRECISION
By identifying the unmet medical needs and difficult-to-treat cancers, we design targeted immune therapies to better help patients. By targeting therapies to cancer cells, the new class of therapies reduce systemic and unintended side effects.
about
Find Out More About Us
CytoCan is a biopharmaceutical company focusing on creating multispecific fusion proteins with a modular platform called AbZed.
Building a LEGO platform for multispecific biologics
CytoCan is devoted to creating First-in-Class medicines to bring benefit to patients. As a modular platform, the AbZed fusion proteins contain three modules: affinity, connector, and cytokine modules. By switching to new antibody fragments or ligands, we can create therapeutic proteins for a new cancer targets. The cytokine module can also be replaced with an affinity module to develop a bi-specific antibody-like protein.
In the News
Press Release - CytoCan received seed round investment
Pipeline
Check our Pipeline
Our Pipeline includes the next generation multispecific HER2, EGFR and TROP targeted therapies.
| Pipeline | Early Discovery | Preclinical | IND Enabling | Phase I Clinical Trial | Indications |
|---|---|---|---|---|---|
| CC-001 HER2_AbZed |
|
breast cancer, gastric cancer | |||
| CC-002 EGFR_AbZed |
|
head & neck cancer, colorectal cancer | |||
| CC-003 Trop-2_AbZed | breast cancer | ||||
Contact
Contact Us
Feel free to contact us by mail, email or phone with your inquiry.
Our Hangzhou office:
A-603-1 Huarun Plaza,
1366 Qianjiang Road
Shangcheng District
Hangzhou City, Zhejiang China
Email Us
contact@cytocan.com
Call Us
15267088941